Trial Profile
European Long-acting Antipsychotics in Schizofrenia Trial EULAST
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 01 Jul 2021
Price :
$35
*
At a glance
- Drugs Aripiprazole (Primary) ; Aripiprazole (Primary) ; Paliperidone (Primary) ; Paliperidone (Primary)
- Indications Schizophrenia
- Focus Therapeutic Use
- Acronyms EULAST
- 31 Aug 2020 Status changed from active, no longer recruiting to completed.
- 27 Aug 2020 This trial has been completed in Denmark, according to European Clinical Trials Database record.
- 27 Aug 2020 This trial has been completed in Denmark, according to European Clinical Trials Database record.